| 685318 |
ONCOTARGETS AND THERAPY |
Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA |
2021-05-01 |
10.2147/ott.s295552 |
Sun Suqing, Wang Peng, Ren Lijie, Wang Hongli, Zhan Yanli, Shan Shimin |
| 685317 |
ONCOTARGETS AND THERAPY |
Targeted Sequencing Facilitated Diagnosis of an Uncommon Patient Harboring Both Multiple Primary and Intrapulmonary Metastatic Lung Cancer: A Case Report |
2021-05-01 |
10.2147/ott.s309155 |
Li Hefei, Dong Shaoyong, Zhang Duo, Guo Zhimin, Li Ce, Xiang Jianxing, Zou Xiao, Yan Li, Sun Ying, Li Wei |
| 685316 |
ONCOTARGETS AND THERAPY |
Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies |
2021-05-01 |
10.2147/ott.s311907 |
Meng Yiming, Sun Jing, Zheng Yang, Zhang Guirong, Yu Tao, Piao Haozhe |
| 685315 |
ONCOTARGETS AND THERAPY |
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC |
2021-05-01 |
10.2147/ott.s310756 |
Peng Ling, Xiao Kui, Cui Jian, Ye Xiang-Hua, Zhang Yong-Chang, Mao Li, Selvaggi Giovanni, Yen Jennifer, Stebbing Justin |
| 685314 |
ONCOTARGETS AND THERAPY |
Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma |
2021-05-01 |
10.2147/ott.s298102 |
Chen Zhan, Zhang Yong, Wu Xiang, Zhang Ji, Xu Wei, Shen Cheng, Zheng Bing |
| 685313 |
ONCOTARGETS AND THERAPY |
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma |
2021-05-01 |
10.2147/ott.s294993 |
Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caicun |
| 685312 |
ONCOTARGETS AND THERAPY |
Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis |
2021-05-01 |
10.2147/ott.s298620 |
Xu Yanzhao, Wang Na, Liu Rongfeng, Lv Huilai, Li Zhenhua, Zhang Fan, Gai Chunyue, Tian Ziqiang |
| 685311 |
ONCOTARGETS AND THERAPY |
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies |
2021-05-01 |
10.2147/ott.s291801 |
Piha-Paul Sarina A, Dumbrava Ecaterina E, Nair Binoj C, Xiong Wendy, Xu Li, Mostorino Rosa, Subbiah Vivek, Tannir Nizar, Fu Siqing, Naing Aung, Janku Filip, Karp Daniel D, Patel Shreyaskumar, Daw Najat C, Hong David, Meric-Bernstam Funda, Zinner Ralph |
| 685310 |
ONCOTARGETS AND THERAPY |
IFNγ/PD-L1 Signaling Improves the Responsiveness of Anti-PD-1 Therapy in Colorectal Cancer: An in vitro Study |
2021-05-01 |
10.2147/ott.s294136 |
Yuan Wenli, Deng Deyao, Li Hanyu, Hu Xinghui, Shang Xueqin, Hou Xia, Jiang Hongchao, He Hongchun |
| 685309 |
ONCOTARGETS AND THERAPY |
Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer |
2021-05-01 |
10.2147/ott.s304297 |
Ma Rui, Qu Xiujuan, Che Xiaofang, Yang Bowen, Li Ce, Hou Kezuo, Guo Tianshu, Xiao Jiawen, Liu Yunpeng |
